Xtreem Pulse, a company based in New York City, was cleared by the FDA to introduce its PureFlow system in the U.S. as a treatment option for patients with chronic stable angina that is refractory to optimal anti-anginal medical therapy while not being able to receive a revascularization procedure. The company says the device is actually intended for use in healthy patients to increase vasodilation, raise the VO2 (ability to perform physical work), and improve overall hemodynamics in athletes and others that are looking to improve their cardiovascular health.
The system relies on a principle called external counter-pulsation. The patient lies on a table with pressure cuffs placed around the calves, thighs, and butt. A heart rate monitor keeps a close track of the heart beats and a computer regulates the pressure cuffs to inflate and deflate with the rhythm of the heart. According to Xtreem Pulse, there is no pain and the sensation is similar to receiving repeated strong hugs around the treated area.
Some of the features of the PureFlow system:
- Patented precise individual cuff control system
- SmoothTouch™ comfort technology
- Patented Triple Pump System
- First automatic ReverseFlow for a variety of lower extremity disorders
Here’s a video from Xtreem Pulse describing its PureFlow system:
Product page: PureFlow…
Via: Xtreem Pulse…